Journals / Türk Otorinolarengoloji Arşivi / 2016 / Cilt: 53 - Sayı: 4

The Effects of Superficial Musculoaponeurotic System Flap on the Development of Frey's Syndrome and Cosmetic Outcomes After Superficial Parotidectomy

Süperfisyel Muskuloaponörotik Sistem Flebinin Süperfisyel Parotidektomi Sonrası Frey Sendromu Gelişimi ve Kozmetik Sonuçlara Etkisi

Pages
158–164
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We determined thatthere was a significant benefit of SMAS flap applicationin the prevention of volume loss and surgicalarea retraction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the outcomes of superficialmusculoaponeurotic system (SMAS) flap and classictechniques in superficial parotidectomy in terms ofFrey's syndrome (FS) and cosmetic satisfaction.Methods: In this study, a retrospective chart reviewof patients that underwent superficial parotidectomywas performed.
📊
Key Findings & Data:These patients were divided into twosubgroups: group 1 included patients in which theSMAS flap was harvested and group 2 comprisedthe remaining patients on whom classic superficialparotidectomy was performed.
💡
Conclusion & Impact:We determined thatthere was a significant benefit of SMAS flap applicationin the prevention of volume loss and surgicalarea retraction.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the outcomes of superficialmusculoaponeurotic system (SMAS) flap and classictechniques in superficial parotidectomy in terms ofFrey's syndrome (FS) and cosmetic satisfaction.Methods: In this study, a retrospective chart reviewof patients that underwent superficial parotidectomywas performed. These patients were divided into twosubgroups: group 1 included patients in which theSMAS flap was harvested and group 2 comprisedthe remaining patients on whom classic superficialparotidectomy was performed. All the patients wereevaluated clinically and with Minor's starch-iodinetest for FS. For the evaluation of the cosmetic results,the patient's satisfaction was queried according to theincision scar and surgical field skin retraction/facialsymmetry. Both groups were compared in terms ofcomplications and numbness of surgical area.Results: Fifty-five patients (31 male and 24 female)with a mean age of 50.19 years were included in thestudy. Thirty-two patients were in group 1 and 23 in ngroup 2. Thirteen patients (23.7%) described as havingFS and six of them were in group 1, while seven were ingroup 2. Minor's starch-iodine test was positive in ninepatients in group 1 (28.1%) and six patients in group 2(26.1%) (p=1.000). With regard to cosmetic satisfaction,eight patients (25%) stated mild discomfort from theincision scar and two patients (6.3%) stated cosmeticdissatisfaction for facial asymmetry in group 1. In group2 for the same factors the number of patients were 11(47.8%) and 2 two (8.7%), respectively (p=0.027). Therewere no statistically significant differences in means ofcomplication and numbness (p>0.05).Conclusion: According to our study results, there wasno superiority between both the groups in terms ofFS and incision scar satisfaction. We determined thatthere was a significant benefit of SMAS flap applicationin the prevention of volume loss and surgicalarea retraction.

Özet

Amaç: Süperfisyel muskuloaponörotik sistem (SMAS)flep ve klasik tekniklerle yapılan süperfisyel parotidektomininFrey Sendromu (FS) ve kozmetik memnuniyetaçısından sonuçlarını incelemek.Yöntemler: Bu çalışmada, süperfisyel parotidektomihastalarının kayıtları retrospektif olarak gözdengeçirildi. Bu hastalar iki alt gruba ayrıldı; grup 1'eSMAS'ın korunduğu hastalar alınırken, grup 2'yi geridekalan ve klasik süperfisyel parotidektomi uygulananhastalar oluşturdu. Tüm hastalar klinik olarakve Minor'ın nişasta-iyot testi ile FS için değerlendirildi.Kozmetik değerlendirme için insizyon skarıve cerrahi alan cilt retraksiyonu / fasial simetri ileilişkili hasta memnuniyeti sorgulandı. Her iki grupkomplikasyon ve cerrahi alan uyuşukluğu açılarındankarşılaştırıldı. olduğunu tanımladı ve bunların altısı grup 1'de iken,yedisi grup 2'deydi. Minor'ın nişasta-iyot testi grup 1'dedokuz hastada (%28.1), grup 2'de altı hastada (%26.1)pozitif idi (p=1.000). Kozmetik memnuniyet açısından,grup 1'de sekiz hasta (%25) cerrahi skar izinden hafifrahatsız iken, iki hasta (%6.3) fasiyal asimetriden memnundeğildi. Aynı faktörler için grup 2'de hastaların sayısısırası ile 11 (%47.8) ve iki (%8.7) idi (p= 0.027). İkigrup arasında komplikasyon varlığı ve cerrahi alandauyuşukluk anlamında istatistiksel olarak anlamlı farklılıkyoktu (p>0.05).Sonuç: Çalışmamızın sonuçlarına göre FS ve insizyonskar memnuniyeti açısından iki grubun birbirine üstünlüğüyoktu. SMAS flep uygulamasının hacim kaybınıve cerrahi alan retraksiyonunu önlemede önemlibir yararı olduğu saptandı.

🔖

Cite This Article

KORKMAZ, M. H., TATAR, E. Ç., SAYLAM, G., SAKA, C., BAYIR, Ö., ÖZDEK, A., ÇELİK, E. K., DAĞLI, M. (2022). The Effects of Superficial Musculoaponeurotic System Flap on the Development of Frey's Syndrome and Cosmetic Outcomes After Superficial Parotidectomy. Türk Otorinolarengoloji Arşivi, Cilt: 53 - Sayı: 4, 158–164. https://ajindex.com/articles/640250

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Clayman MA, Clayman SM, Seagle MB. A review of the surgical and medical treatment of Frey syndrome. Ann Plast Surg 2006
  2. [CrossRef ] 2. Luers JC, Guntinas-Lichius O, Klussmann JP, Küsgen C, Beutner D, Grosheva M. The incidence of Warthin tumours and pleomorphic adenomas in the parotid gland over a 25-year period. Clin Otolaryngol 2016
  3. [CrossRef ] 3. Sood S, Quraishi MS, Bradley PJ. Frey's syndrome and parotid surgery. Clin Otolaryngol Allied Sci 1998
  4. [CrossRef ] 4. de Bree R, van der Waal I, Leemans CR. Management of Frey syndrome. Head Neck 2007
  5. [CrossRef ] 5. Marchese-Ragona R, De Filippis C, Marioni G, Staffieri A. Treatment of complications of parotid gland surgery. Acta Otorhinolaryngol Ital 2005
  6. Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST. Parotid tumors: a 10-year experience. Am J Otolaryngol 2008
  7. [CrossRef ] 7. Tuncel A, Karaman M, Sheidaei S, Tatlıpınar A, Esen E. A comparison of incidence of Frey's syndrome diagnosed based on clinical signs and Minor's test after parotis surgery. Kulak Burun Bogaz Ihtis Derg 2012
  8. [CrossRef ] 8. Takahama Junior A, Almeida OP, Kowalski LP. Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol 2009
  9. [CrossRef ] 9. Rustemeyer J, Eufinger H, Bremerich A. The incidence of Frey's syndrome. J Craniomaxillofac Surg 2008
  10. [CrossRef ] 10. Nitzan D, Kronenberg J, Horowitz Z, Wolf M, Bedrin L, Chaushu G, et al. Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg 2004
  11. [CrossRef ] 11. Perzik SL. End results in parotid tumors. Calif Med 1957
  12. Redaelli de Zinis LO, Piccioni M, Antonelli AR, Nicolai P. Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol 2008
  13. [CrossRef ] 13. Harada T, Inoue T, Harashina T, Hatoko M, Ueda K. Dermis-fat graft after parotidectomy to prevent Frey's syndrome and the concave deformity. Ann Plast Surg 1993
  14. [CrossRef ] 14. Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Lehmann W. Frey syndrome treatment with botulinum toxin. Otolaryngol Head Neck Surg 2000
  15. [CrossRef ] 15. Pomprasit M, Chintrakarn C. Treatment of Frey's syndrome with botulinum toxin. J Med Assoc Thai 2007
  16. Yoo YM, Lee JS, Park MC, Kim